Previous close | 16.20 |
Open | 16.10 |
Bid | 18.10 |
Ask | 20.60 |
Strike | 230.00 |
Expiry date | 2024-12-20 |
Day's range | 16.70 - 18.40 |
Contract range | N/A |
Volume | |
Open interest | 108 |
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER.
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.